| 中文名称 |
Flucloxacillin sodium
|
| 中文别名 |
氟氯西林钠;(2S,5R,6R)-6-[[3-(2-氯-6-氟苯基)-5-甲基-1,2-恶唑-4-甲酰]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-甲酸钠盐;比沙可啶;氟氯西林钠 EP标准品;氟氯西林钠 标准品;氟氯西林钠(口服);氟氯西林钠(注射级);福莫特罗富马酸盐;依巴斯汀;氟;氟氯西林钠,Flucloxacillin sodium,分析标准品;氟氯西林钠(无菌);氟氯西林钠(标准品)
|
| 英文名称 |
Flucloxacillin sodium
|
| 英文别名 |
flucloxacillin sodium;Sodium (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;mfi-pc;Gulpen;NSC 277175;FK 900 sodium;Flucloxacilli;floxapensodium;Staphylex Sodiu;BRL 2039 sodium;Staphylex Sodium;floxacillinsodium;Floxacillin sodium;Floxapen sodium;Flucloxacillin sodium salt;Floxacillin Na salt;Sodium flucloxacillin;Monosodium flucloxacillin;Stafopen sodium salt;Staphylex Sodium salt;Floxacillin sodium salt;Flucloxacillin-Sodium;05F65O42VK;Floxapen (TN);5-Methyl-3-(2-chloro-6-fluorophenyl)-4-isoxazolylpenicillin sodium;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl;Flucloxacillin sodium
|
| Cas No. |
1847-24-1
|
| 分子式 |
C19H16ClFN3NaO5S
|
| 分子量 |
475.85
|
| 包装储存 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| 详情描述 |
Flucloxacillin sodium 是高活性的抗革兰氏阳性和革兰氏阴性菌的抗生素 (antibiotic)。
|
| 产品详情 |
Flucloxacillin sodium 是高活性的抗革兰氏阳性和革兰氏阴性菌的抗生素 (antibiotic)。
|
| 生物活性 |
Flucloxacillin sodium is an active antibiotic against gram-positive and gram-negative bacteria.
|
| 性状 |
Solid
|
| IC50 & Target[1][2] |
Bacterial
|
| 体内研究(In Vivo) |
Flucloxacillin sodium (200 mg/kg; i.p.; three times/day, for 21 days; male Wistar rats) has effective against the most common bacterial strains in periprosthetic infection. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| ClinicalTrial |
|
| 参考文献 |
[1]. Greimel F, et, al. Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study. Drug Des Devel Ther. 2017 Jun 14;11:1729-1736. [2]. Comber KR, Merrikin DJ, Sutherland R. Antibacterial activity and synergy, in vitro and in vivo, of a combination of amoxycillin and flucloxacillin. Chemotherapy. 1979;25(1):30-9.
|
| 溶解度数据 |
In Vitro: H2O : 100 mg/mL (210.15 mM; Need ultrasonic)DMSO : ≥ 100 mg/mL (210.15 mM)
|
[1]. Greimel F, et, al. Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study. Drug Des Devel Ther. 2017 Jun 14;11:1729-1736. [2]. Comber KR, Merrikin DJ, Sutherland R. Antibacterial activity and synergy, in vitro and in vivo, of a combination of amoxycillin and flucloxacillin. Chemotherapy. 1979;25(1):30-9.
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。